speb/financial-data huggingface dataset:
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 14033000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 65001000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 2812000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 5362000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 8174000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 847000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 847000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 60851000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 0.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 0.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Depreciation: 2488000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 4758000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 4758000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 4758000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 4758000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 64246000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 227000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — EBIT: 1951000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — EBITDA: 6709000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 11165000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -3482000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 5563000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: -80000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 8360000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Goodwill: 70011000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 102170000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 90656000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 26593000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 1724000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 1724000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Interest Income: -21000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: -21000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -864000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 36000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 18627000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 131011000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -1811000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 500000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 35062000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 39250000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 74312000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 500000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -2741000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: -377000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Net Debt: 33447000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Net Income: 227000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 227000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 227000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 227000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 227000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 227000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 227000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -159000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -1745000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -2241000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -2241000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -1745000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 56342000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -1652000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: -15771000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 7336000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Normalized Income: 854000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 7374000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 80000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Operating Income: 2599000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 89550000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 62742307.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 2202000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 5362000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1316000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: -627000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 32159000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 1775000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 1951000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 10876000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Other Payable: 4425000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Payables: 36397000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 50430000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 84000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 227000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -159000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -1652000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 32527000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 62957000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 4758000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -2741000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: -377000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 480000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 547000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -286962000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 8360000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 8360000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 62742307.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Special Income Charges: -627000.00
CRRX.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 422000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 86399000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: -15771000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 76000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 223513000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 125649000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 82486000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 86399000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 86951000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 137114000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 158512000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 76263000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 2002000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -627000.00
CRRX.TO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -627000.00
CRRX.TO balance_sheet (quarterly, 2025-03-31) — Working Capital: 4150000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — +Operating Expense: 24194000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — +Total Revenue: 91390000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 27613000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 32189000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -35115000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 39788000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 1960000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 1960000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 62999594.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 11165000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -2129000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 38375000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 333559000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 8690000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 8690000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -4115000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -2129000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 3769000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -4064000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Change In Inventory: 220000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Change In Payable: -4064000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -4064000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 855000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -1228000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -4217000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -2475000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Common Stock: 333559000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 86946000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Common Stock Payments: -538000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 64268000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 16881000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Current Assets: 61189000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 2950000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Current Debt: 5115000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 8065000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 133000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 133000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 56564000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Depreciation: 2582000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 4542000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 4543000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 4542000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 4543000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 64974136.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 561000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — EBIT: 2312000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — EBITDA: 6855000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — End Cash Position: 8690000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -4115000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 1640000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Ppe: -206000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 8146000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Goodwill: 70011000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 100648000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 91588000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Gross Profit: 27122000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 0.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Interest Expense: 1751000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1751000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Interest Income: 28000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 28000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -850000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Interest Received Cfo: 28000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Inventory: 17080000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 130439000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -2129000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 500000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 35425000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 38378000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 73803000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 500000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -3240000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -525000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Net Debt: 34803000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Net Income: 561000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 561000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 561000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 561000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 561000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 561000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 561000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -447000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Net Interest Income: -1723000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -2740000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -2740000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1723000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Net PPE: 56473000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1682000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: -13702000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 250000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 7499000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Normalized Income: 1205000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 3769000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 206000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Operating Income: 2928000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Operating Revenue: 91390000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 63090907.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 2674000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 5115000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 2110000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Other Income Expense: -644000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 30637000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2123000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 747000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 11505000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Other Payable: 1562000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Payables: 29175000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 46056000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 200000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Pretax Income: 561000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -447000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1682000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Receivables: 32265000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 64269000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 4542000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -3240000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: -538000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 480000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 438000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -286401000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Salaries And Wages: 8146000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 8146000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Share Issued: 63090907.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Special Income Charges: -644000.00
CRRX.TO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 526000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 86946000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: -13702000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 76000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Total Assets: 218310000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 125324000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Total Debt: 81868000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 86946000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Total Expenses: 88462000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 131364000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 157121000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 74800000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 2299000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -644000.00
CRRX.TO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -644000.00
CRRX.TO balance_sheet (quarterly, 2025-06-30) — Working Capital: 4625000.00
CRRX.TO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 61597000.00
CRRX.TO balance_sheet (quarterly, 2025-09-30) — Dividends Payable: 1260000.00
CRRX.TO balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 790000.00
CRRX.TO balance_sheet (quarterly, 2025-09-30) — Payables: 37583000.00
CRRX.TO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 51113000.00
CRRX.TO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 74809000.00
CRRX.TO balance_sheet (quarterly, 2025-09-30) — Working Capital: 8165000.00
CRRX.TO income_statement (annual, 2025-12-31) — +Operating Expense: 99080000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — +Operating Expense: 26100000.00
CRRX.TO income_statement (annual, 2025-12-31) — +Total Revenue: 370241000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — +Total Revenue: 96081000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Accounts Payable: 33893000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 33893000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 32390000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 32390000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -39082000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -39082000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 40591000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 40591000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 8071000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 1911000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 8071000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 1911000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 0.00
CRRX.TO income_statement (annual, 2025-12-31) — Basic Average Shares: 62734000.00
CRRX.TO income_statement (annual, 2025-12-31) — Basic EPS: 0.42
CRRX.TO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 9084000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 15541000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Capital Expenditure: -8298000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -3212000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 36864000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 36864000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Capital Stock: 332491000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 332491000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 13919000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 13919000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 13919000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 13919000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -1259000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -1259000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -17719000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -8021000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -8259000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -3195000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 30813000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 9594000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Change In Account Payable: -891000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 2481000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Change In Inventory: -126000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Change In Inventory: -1215000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Change In Payable: -891000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Change In Payable: 2481000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -891000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 2481000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -218000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -326000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Change In Receivables: 247000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 20000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Change In Working Capital: -988000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 960000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Changes In Cash: 4835000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -1622000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Common Stock: 332491000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock: 332491000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -1259000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 109504000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 109504000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 14000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 1000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Common Stock Payments: -2239000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -799000.00
CRRX.TO income_statement (annual, 2025-12-31) — Cost Of Revenue: 259278000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 66979000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 12549000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 12549000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Current Assets: 67015000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Current Assets: 67015000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 2772000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 2772000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Current Debt: 5097000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Current Debt: 5097000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 7869000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 7869000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 758000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 758000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 758000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 758000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Current Liabilities: 63033000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 63033000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Deferred Income Tax: -22774000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Deferred Tax: -22774000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Depreciation: 10262000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Depreciation: 2632000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 18333000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 4543000.00
CRRX.TO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 18332000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 4542000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 18333000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 4543000.00
CRRX.TO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 18332000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 4542000.00
CRRX.TO income_statement (annual, 2025-12-31) — Diluted Average Shares: 64491000.00
CRRX.TO income_statement (annual, 2025-12-31) — Diluted EPS: 0.41
CRRX.TO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 26127000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 23789000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Dividends Payable: 1256000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Dividends Payable: 1256000.00
CRRX.TO income_statement (annual, 2025-12-31) — EBIT: 10197000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — EBIT: 2770000.00
CRRX.TO income_statement (annual, 2025-12-31) — EBITDA: 28530000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — EBITDA: 7313000.00
CRRX.TO cash_flow (annual, 2025-12-31) — End Cash Position: 13919000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — End Cash Position: 13919000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -17719000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -8021000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Free Cash Flow: 22515000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 6382000.00
CRRX.TO income_statement (annual, 2025-12-31) — Gain On Sale Of Ppe: -479000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Ppe: -199000.00
CRRX.TO income_statement (annual, 2025-12-31) — General And Administrative Expense: 34228000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 9682000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Goodwill: 70011000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Goodwill: 70011000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 98899000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 98899000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Gross PPE: 93341000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 93341000.00
CRRX.TO income_statement (annual, 2025-12-31) — Gross Profit: 110963000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Gross Profit: 29102000.00
CRRX.TO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
CRRX.TO income_statement (annual, 2025-12-31) — Interest Expense: 6844000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Interest Expense: 1755000.00
CRRX.TO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 6844000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 1755000.00
CRRX.TO income_statement (annual, 2025-12-31) — Interest Income: 161000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Interest Income: 54000.00
CRRX.TO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 161000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 54000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Interest Paid Cff: -3277000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -1563000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Interest Received Cfo: 161000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Interest Received Cfo: 54000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Inventory: 17545000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Inventory: 17545000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Invested Capital: 150565000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 150565000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -8259000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -3195000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 14000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 1000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Issuance Of Debt: 1000000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Leases: 47946000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Leases: 47946000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 34092000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 34092000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Long Term Debt: 35964000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 35964000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 70056000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 70056000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 1000000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
CRRX.TO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -11958000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -4401000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 30908000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 30908000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -2225000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -798000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Net Debt: 27142000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Net Debt: 27142000.00
CRRX.TO income_statement (annual, 2025-12-31) — Net Income: 26127000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Net Income: 23789000.00
CRRX.TO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 26127000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 23789000.00
CRRX.TO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 26127000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 23789000.00
CRRX.TO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 26127000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 23789000.00
CRRX.TO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 26127000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 23789000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 26127000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 23789000.00
CRRX.TO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 26127000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 23789000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -2713000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -1869000.00
CRRX.TO income_statement (annual, 2025-12-31) — Net Interest Income: -6683000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Net Interest Income: -1543000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -10958000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -4401000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -10958000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -4401000.00
CRRX.TO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -6683000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1543000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Net PPE: 54259000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Net PPE: 54259000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -5546000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1326000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 10605000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 10605000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 22774000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 22774000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 22774000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 22774000.00
CRRX.TO income_statement (annual, 2025-12-31) — Normalized EBITDA: 30377000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7760000.00
CRRX.TO income_statement (annual, 2025-12-31) — Normalized Income: 27696950.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Normalized Income: 24168950.00
CRRX.TO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 30813000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 9594000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Operating Gains Losses: 479000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 199000.00
CRRX.TO income_statement (annual, 2025-12-31) — Operating Income: 11883000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Operating Income: 3002000.00
CRRX.TO income_statement (annual, 2025-12-31) — Operating Revenue: 370241000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Operating Revenue: 96081000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 62781495.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 62781495.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Other Current Assets: 2170000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2170000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 5097000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 5097000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1892000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1892000.00
CRRX.TO income_statement (annual, 2025-12-31) — Other Income Expense: -1847000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Other Income Expense: -447000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 28888000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 28888000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Other Non Cash Items: 6760000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 1558000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 354000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 354000.00
CRRX.TO income_statement (annual, 2025-12-31) — Other Operating Expenses: 46520000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 11876000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Other Payable: 4659000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Other Payable: 4659000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Other Properties: 14487000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Other Properties: 14487000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Payables: 39808000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Payables: 39808000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 52357000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 52357000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 157000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 157000.00
CRRX.TO income_statement (annual, 2025-12-31) — Pretax Income: 3353000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Pretax Income: 1015000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Properties: 0.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CRRX.TO cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -2713000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -1869000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -5585000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1343000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Receivables: 32901000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Receivables: 32901000.00
CRRX.TO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 259277000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 66978000.00
CRRX.TO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 18333000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 4543000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -11958000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -4401000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -2239000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -799000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Restricted Cash: 480000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 480000.00
CRRX.TO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 1368000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 248000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Retained Earnings: -263578000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -263578000.00
CRRX.TO income_statement (annual, 2025-12-31) — Salaries And Wages: 34228000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 9682000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Sale Of PPE: 39000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 17000.00
CRRX.TO income_statement (annual, 2025-12-31) — Selling General And Administration: 34228000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 9682000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Share Issued: 62781495.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Share Issued: 62781495.00
CRRX.TO income_statement (annual, 2025-12-31) — Special Income Charges: -1847000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Special Income Charges: -447000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 2715000.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1265000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 109504000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 109504000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 10605000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 10605000.00
CRRX.TO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -277050.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -67050.00
CRRX.TO income_statement (annual, 2025-12-31) — Tax Provision: -22774000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Tax Provision: -22774000.00
CRRX.TO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.15
CRRX.TO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
CRRX.TO balance_sheet (annual, 2025-12-31) — Taxes Receivable: 511000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 511000.00
CRRX.TO cash_flow (annual, 2025-12-31) — Taxes Refund Paid: 0.00
CRRX.TO cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: 0.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Total Assets: 242947000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Total Assets: 242947000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Total Capitalization: 145468000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 145468000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Total Debt: 77925000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Total Debt: 77925000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 109504000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 109504000.00
CRRX.TO income_statement (annual, 2025-12-31) — Total Expenses: 358358000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Total Expenses: 93079000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 133443000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 133443000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 175932000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 175932000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 70410000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 70410000.00
CRRX.TO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 10113000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 2573000.00
CRRX.TO income_statement (annual, 2025-12-31) — Total Unusual Items: -1847000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items: -447000.00
CRRX.TO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1847000.00
CRRX.TO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -447000.00
CRRX.TO balance_sheet (annual, 2025-12-31) — Working Capital: 3982000.00
CRRX.TO balance_sheet (quarterly, 2025-12-31) — Working Capital: 3982000.00
CRRX.TO income_statement (quarterly, 2026-03-31) — +Operating Expense: 24933000.00
CRRX.TO income_statement (quarterly, 2026-03-31) — +Total Revenue: 93923000.00
CRRX.TO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 36341000.00
CRRX.TO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 33383000.00
CRRX.TO balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -40519000.00
CRRX.TO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 41103000.00
CRRX.TO cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 1983000.00
CRRX.TO cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 1983000.00